FDA Drugs (New Approvals & NDA)Original article
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
RegulatoryCefazolin in Dextrose Injection, USP, 2G / 100ML (20MG / ML)Negative
AI Analysis
Summary
Baxter International voluntarily recalled Lot LD175708 of Cefazolin in Dextrose Injection (expiring Feb 14, 2027) due to discovery of cardboard particulate matter in the solution. The recall was issued on July 24, 2026.
Outcome Details
Voluntary nationwide recall of Cefazolin in Dextrose Injection due to particulate matter (cardboard) found in solution
Importance:4/10
Sentiment:
-0.80
product recallquality issueFDAsafety
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 24, 2026 9:46 PM